Aptargroup
ATR · NYSE
About ATR
- Employees
- 14,000
- Headquarters
- Crystal Lake, Illinois
- Listed
- Apr 23, 1993
- Sector
- Materials
- Industry
- Containers & Packaging
- Website
- aptar.com
ATR key statistics
- Market cap
- 8.00B
- Price-earnings ratio
- 22.50
- Dividend yield
- 1.54%
- Average volume
- 464.21K
- Volume
- 356.89K
- Open price
- $124.49
- High today
- $126.01
- Low today
- $124.02
- 52 Week high
- $146.91
- 52 Week low
- $103.23
Aptargroup (ATR) at a glance
Aptargroup (ATR) last traded at $125.77, with a market cap of 8.00B, a price-to-earnings ratio of 22.50 and a dividend yield of 1.54%.
Today the stock has traded between $124.02 and $126.01. The current price is 1.4% above the day's low and 0.2% below its high.
Volume so far is 356.89K shares, below the average of 464.21K shares a day.
Over the past year Aptargroup has ranged from $103.23 to $146.91, and now sits 52% of the way up that range.
Aptargroup met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $1.42 per share against an estimate of $1.37.
The average analyst price target is $172.17, 36.9% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $156.11
- Now
- $125.77
- High
- $231.00
ATR earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 5.8% on average.
- Q3 FY24: reported $1.49 per share against an estimate of $1.43
- Q4 FY24: reported $1.52 per share against an estimate of $1.28
- Q1 FY25: reported $1.20 per share against an estimate of $1.17
- Q2 FY25: reported $1.66 per share against an estimate of $1.58
- Q3 FY25: reported $1.62 per share against an estimate of $1.58
- Q4 FY25: reported $1.25 per share against an estimate of $1.16
- Q1 FY26: reported $1.19 per share against an estimate of $1.16
- Q2 FY26: reported $1.42 per share against an estimate of $1.37
ATR news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
- Press releaseBusiness Wire
Aptar Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
- Press releaseBusiness Wire
Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing
- Press releaseBusiness Wire
Aptar Declares Quarterly Dividend
- Press releaseBusiness Wire
Aptar Named Among Top 100 of America’s Best Companies by TIME
- Press releaseBusiness Wire
Aptar Releases 2025 Corporate Sustainability Report
Similar companies
Companies in the same industry as Aptargroup
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.